Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.
2.
3.
4.

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes.

Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW, Hiatt WR.

Circulation. 2003 Feb 11;107(5):753-6.

5.

Intensively lowering both low-density lipoprotein cholesterol and blood pressure does not reduce cardiovascular risk in Japanese coronary artery disease patients.

Kohro T, Yamazaki T, Izumi T, Daida H, Kurabayashi M, Miyauchi K, Tojo T, Nagai R; JCADII Investigators.

Circ J. 2011;75(9):2062-70. Epub 2011 Aug 3.

6.

Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Tuomilehto J, Rastenyte D, Birkenhäger WH, Thijs L, Antikainen R, Bulpitt CJ, Fletcher AE, Forette F, Goldhaber A, Palatini P, Sarti C, Fagard R.

N Engl J Med. 1999 Mar 4;340(9):677-84.

7.

The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus.

Huang ES, Meigs JB, Singer DE.

Am J Med. 2001 Dec 1;111(8):633-42.

PMID:
11755507
8.

Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.

Bangalore S, Kumar S, Lobach I, Messerli FH.

Circulation. 2011 Jun 21;123(24):2799-810, 9 p following 810. doi: 10.1161/CIRCULATIONAHA.110.016337. Epub 2011 May 31.

9.

Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.

ACCORD Study Group, Buse JB, Bigger JT, Byington RP, Cooper LS, Cushman WC, Friedewald WT, Genuth S, Gerstein HC, Ginsberg HN, Goff DC Jr, Grimm RH Jr, Margolis KL, Probstfield JL, Simons-Morton DG, Sullivan MD.

Am J Cardiol. 2007 Jun 18;99(12A):21i-33i. Epub 2007 Apr 16.

PMID:
17599422
10.

Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?

Zanchetti A, Hansson L, Clement D, Elmfeldt D, Julius S, Rosenthal T, Waeber B, Wedel H; HOT Study Group.

J Hypertens. 2003 Apr;21(4):797-804.

PMID:
12658027
11.

[Clinical features and risk factors of renal damage in elderly and non-elderly patients with type 2 diabetes mellitus].

Huang H, Li H, Zheng FP, Lu WN, Dong XH, Ruan Y.

Zhonghua Yi Xue Za Zhi. 2010 Apr 13;90(14):967-71. Chinese.

PMID:
20646646
12.

Isolated systolic hypertension: pathophysiology, consequences and therapeutic benefits.

Kocemba J, Kawecka-Jaszcz K, Gryglewska B, Grodzicki T.

J Hum Hypertens. 1998 Sep;12(9):621-6. Review.

PMID:
9783491
13.

Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis.

Zhang CY, Sun AJ, Zhang SN, Wu CN, Fu MQ, Xia G, Wang KQ, Zou YZ, Ge JB.

Ann Med. 2010 May 6;42(4):305-15. doi: 10.3109/07853891003796752.

PMID:
20429797
14.

New treatment guidelines for a patient with diabetes and hypertension.

Mogensen CE.

J Hypertens Suppl. 2003 Mar;21(1):S25-30. Review.

PMID:
12769164
15.

The natural history of borderline isolated systolic hypertension.

Sagie A, Larson MG, Levy D.

N Engl J Med. 1993 Dec 23;329(26):1912-7.

16.

Redefining blood pressure targets in high-risk patients?: lessons from coronary endpoints in recent randomized clinical trials.

Volpe M, Tocci G.

Am J Hypertens. 2011 Oct;24(10):1060-8. doi: 10.1038/ajh.2011.105. Epub 2011 Jun 16. Review.

PMID:
21677698
17.

Discordance of influence of hypertension on mortality and cardiovascular risk in hemodialysis patients.

Takeda A, Toda T, Fujii T, Shinohara S, Sasaki S, Matsui N.

Am J Kidney Dis. 2005 Jan;45(1):112-8.

PMID:
15696450
18.
19.

What matters in ADVANCE and ADVANCE-ON.

Hamet P.

Diabetes Obes Metab. 2012 Jan;14 Suppl 1:20-9. doi: 10.1111/j.1463-1326.2011.01509.x. Review.

PMID:
22118707
20.

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

Staessen JA, Wang JG, Thijs L.

J Hypertens. 2003 Jun;21(6):1055-76.

PMID:
12777939

Supplemental Content

Support Center